Home
About
Calendar
News
Partners
Learn more
Oncology News
09.8
2025
Four-Year Median OS with Osimertinib/ Chemotherapy Combination in Advanced EGFR-Mutation Positive NSCLC
07.2
2025
FDA Approves Sunvozertinib for EGFR Exon 20 Insertion-Positive Metastatic NSCLC
Previous Page
Upcoming Events
May
29
May 29
–
June 2
ASCO Annual Meeting
View Calendar
